![Toby Ferguson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Toby Ferguson
Corporate Officer/Principal bei
Temple University School of Medicine
Vermögen: 748 353 $ am 31.08.2026
Profil
Toby Ferguson is currently an Assistant Professor-Neurology at Temple University School of Medicine.
Formerly, Dr. Ferguson was Chief Medical Officer at Voyager Therapeutics, Inc. from 2024 to 2026 and VP & Head-Neuromuscular Development Unit at Biogen, Inc. from 2020 to 2024.
Education includes a doctorate from the University of Florida College of Medicine and an undergraduate degree from the University of Florida.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 216’914 ( 0.35% ) | 748 353 $ | 31.08.2026 |
Aktive Positionen von Toby Ferguson
| Unternehmen | Position | Beginn |
|---|---|---|
Temple University School of Medicine
 Temple University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Toby Ferguson
| Unternehmen | Position | Ende |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 20.02.2026 |
| BIOGEN INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2019 |
Ausbildung von Toby Ferguson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
89
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Temple University School of Medicine
Temple University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Florida College of Medicine
 University of Florida College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
